Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of Clinical Pharmacology|January 26, 2010
PhRMA survey on the conduct of first-in-human clinical trials under exploratory investigational new drug applicationsAdel H Karara, Timi Edeki, James McLeod, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 17, 2015
Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime-avibactam in healthy Japanese volunteersNobumitsu Tominaga, Timi Edeki, James Li, et al.International Journal of Clinical Pharmacology and Therapeutics|July 9, 2015
Evaluation of the pharmacokinetics and safety of single and multiple ceftaroline fosamil infusions in healthy Chinese and Western subjectsLi Yang, Maria Sunzel, Peng Xu, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2014
Assessment of the mass balance recovery and metabolite profile of avibactam in humans and in vitro drug-drug interaction potentialKarthick Vishwanathan, Stuart Mair, Anshul Gupta, et al.The Journal of Antimicrobial Chemotherapy|July 3, 2015
Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimensDavid P Nicolau, Leonard Siew, Jon Armstrong, et al.Critical Care (London, England)|February 21, 2012
A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shockPeter E Morris, Brian Zeno, Andrew C Bernard, et al.Clinical Therapeutics|June 6, 2006
Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjectsLinda E Gustavson, Sarah M Schweitzer, David A Burt, et al.Journal of Clinical Pharmacology|July 20, 2005
A phase I multiple-dose escalation study characterizing pharmacokinetics and safety of ABT-578 in healthy subjectsChetan S Karyekar, Rajendra S Pradhan, Tony Freeney, et al.JAMA|January 16, 2002
Risk of dementia among white and African American relatives of patients with Alzheimer diseaseRobert C Green, L Adrienne Cupples, Rodney Go, et al.Archives of Neurology|May 21, 2003
Depression as a risk factor for Alzheimer disease: the MIRAGE StudyRobert C Green, L Adrienne Cupples, Alex Kurz, et al.Pageof 3